-
New guidelines from the ACP suggest that rather than universal screening, women aged 40-49 should be assessed for individual risk of breast cancer, and should be informed of the potential benefits and harms of screening mammography, then selectively screened based on the findings.
-
-
A variety of peptide markers in the blood and CSF have been identified by proteomic techniques and should increase our ability to identify, at an early stage, those patients at risk for developing Alzheimer's dementia (AD).
-
This is the first ever published phase I clinical trial testing gene therapy in Parkinson's disease( PD).
-
TCD and MRA have a low positive predictive value in diagnosing clinically significant intracranial stenosis, but are useful as screening tests to rule-out significant lesions.
-
The time to secondary progression and irreversible disability in childhood-onset MS is slower as compared to adult-onset disease. However, it occurs at a younger age.
-
The most common cause of bilateral vestibulopathy remains ototoxicity from antibiotics, such as gentamicin.
-
SSRIs are associated with a low rate of birth defects according to 2 new studies in the New England Journal of Medicine.
-
EMG studies are helpful in a minority of patients with suspected sacral plexopathy. Clinical examination and imaging provide more useful information.
-
GlaxoSmithKline's rosiglitazone (Avandia) will receive a black box warning by the FDA because of concerns over heart failure associated with use of the drug.